Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-045321
Filing Date
2024-04-10
Accepted
2024-04-09 19:11:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2411278-1_424b5.htm 424B5 456365
2 GRAPHIC lg_eyenovia-4clr.jpg GRAPHIC 27959
  Complete submission text file 0001104659-24-045321.txt   496045
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261638 | Film No.: 24833880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)